Header Logo

Connection

Jeff Slezak to Survival Rate

This is a "connection" page, showing publications Jeff Slezak has written about Survival Rate.
Connection Strength

0.380
  1. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer. Am J Clin Oncol. 2014 Oct; 37(5):486-91.
    View in: PubMed
    Score: 0.116
  2. Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population. BJU Int. 2017 10; 120(4):520-529.
    View in: PubMed
    Score: 0.034
  3. Histopathologic grading of adult medulloblastomas. Cancer. 2007 Jun 15; 109(12):2557-65.
    View in: PubMed
    Score: 0.017
  4. Radical prostatectomy for octogenarians: how old is too old? Urology. 2006 Nov; 68(5):1042-5.
    View in: PubMed
    Score: 0.017
  5. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol. 2006 Sep; 176(3):1118-21.
    View in: PubMed
    Score: 0.016
  6. Follow-up study of long-term survivors of osteosarcoma in the prechemotherapy era. Hum Pathol. 2006 Aug; 37(8):1009-14.
    View in: PubMed
    Score: 0.016
  7. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol. 2006 Feb; 175(2):547-51.
    View in: PubMed
    Score: 0.016
  8. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol. 2005 Apr; 173(4):1121-5.
    View in: PubMed
    Score: 0.015
  9. Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation. Am J Kidney Dis. 2005 Jan; 45(1):102-11.
    View in: PubMed
    Score: 0.015
  10. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003 Nov; 170(5):1872-6.
    View in: PubMed
    Score: 0.014
  11. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. J Urol. 2002 Sep; 168(3):1204-11.
    View in: PubMed
    Score: 0.012
  12. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer. 2002 Aug; 34(4):363-71.
    View in: PubMed
    Score: 0.012
  13. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000 Feb; 13(2):113-8.
    View in: PubMed
    Score: 0.010
  14. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999 Nov 01; 86(9):1775-82.
    View in: PubMed
    Score: 0.010
  15. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999 Jul; 23(7):803-8.
    View in: PubMed
    Score: 0.010
  16. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology. 1999 Jul; 54(1):105-10.
    View in: PubMed
    Score: 0.010
  17. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol. 1999 Apr; 161(4):1223-7; discussion 1227-8.
    View in: PubMed
    Score: 0.010
  18. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. J Urol. 1999 Apr; 161(4):1233-7.
    View in: PubMed
    Score: 0.010
  19. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol. 1999 Mar; 161(3):857-62; discussion 862-3.
    View in: PubMed
    Score: 0.010
  20. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology. 1997 Nov; 50(5):733-9.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente